Global Precision Medicine Market

Global Precision Medicine Market Trend and Development Strategy Analysis 2023-2029

Global Precision Medicine Market

Global Precision Medicine Market Trend and Development Strategy Analysis 2023-2029


Get latest Market Research Reports on . Industry analysis and Market Report on is a syndicated market report, published as Global Market Research Report . It is complete Research Study and Industry Analysis of market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

Market Analysis and Insights: Global Precision Medicine Market

The global Precision Medicine market size in 2022 is 7330.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 12.60% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:

The main players in the Precision Medicine market include Moderna, Inc. (U.S.), Personalis, Inc. (U.S.), CureVac SE (Germany), Celldex Therapeutics (U.S.), and BioNTech SE (Germany). The share of the top 3 players in the Precision Medicine market is XX%.

REGION SHARE:

The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Precision Medicine market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:

The report segments the market by Type and Application. Alectinib accounted for XX% of Precision Medicine market in 2022. Osimertinib share of XX%.

Oncology accounted for XX% of the Precision Medicine market in 2022. Central Nervous System (CNS) Disorders accounts for XX%.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Precision Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Precision Medicine market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Precision Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Precision Medicine market.

Global Precision Medicine Scope and Market Size

Precision Medicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Precision Medicine market will be able to gain the upper hand as they use the report as a powerful resource.

The impact of the outbreak of COVID-19 and the Russia-Ukraine War on the Precision Medicine industry is considered in the report, covering the dynamic analysis of the development of the Precision Medicine industry, including trends, technologies, opportunities, constraints. To ensure report buyers are able to gain in-depth knowledge of the market.

The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.

Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.

Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.

Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.

Market Data Breakdown by Regions

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Spain

Nordic

Asia Pacific

China

Japan

South Korea

India

Southeast Asia

Australia

Latin America

Brazil

Mexico

Argentina

Middle East & Africa

Egypt

South Africa

UAE

Turkey

Saudi Arabia

Some prominent players in the market includes:

Moderna, Inc. (U.S.)

Personalis, Inc. (U.S.)

CureVac SE (Germany)

Celldex Therapeutics (U.S.)

BioNTech SE (Germany)

Advaxis, Inc. (U.S.)

Agenus Inc. (U.S.)

Immatics Biotechnologies GmbH (Germany)

Gritstone Oncology (U.S.)

ImmunityBio, Inc. (U.S.)

bioMérieux SA (France)

Bayer AG (Germany)

Pfizer Inc. (U.S.)

GSK plc (U.K.)

F. Hoffmann-La Roche Ltd. (Switzerland)

Market Data Breakdown by Type

Alectinib

Osimertinib

Mepolizumab

Aripiprazole Lauroxil,

Others

Market Data Breakdown by Applications

Oncology

Central Nervous System (CNS) Disorders

Immunology Disorders

Respiratory Disorders

Others

Table of Content

1 Precision Medicine Market Introduction and Overview

1.1 Precision Medicine Definition

1.2 Research Purposes

1.3 Report Timeline

1.4 Economic Analysis of Global Regions

1.5 Precision Medicine Industry Dynamic Analysis

1.5.1 Precision Medicine Market Trends Analysis

1.5.2 Precision Medicine Market Drivers Analysis

1.5.3 Precision Medicine Market Challenges Analysis

1.5.4 Precision Medicine Market Restraints Analysis

1.6 Inflation Analysis

1.7 The Impact of the Russian-Ukrainian War on the Market

1.8 Coronavirus Disease 2020 (COVID-19) Impact on Global

2 Global Precision Medicine Market Insights by Type

2.1 Market Size Insights by Types

2.2 Global Precision Medicine Revenue and Share by Type

3 Global Precision Medicine Market Insights by Application

3.1 Market Size Insights by Application

3.2 Global Precision Medicine Revenue and Share by Application (2018-2023)

4 Global Market Growth Insights

4.1 Global Precision Medicine Market Size (2018-2023)

4.2 Precision Medicine Growth Insights by Regions

4.2.1 Precision Medicine Market Size by Regions: 2018 VS 2023 VS 2029

4.2.2 Precision Medicine Revenue Market Size by Regions (2018-2023)

4.2.3 North America Precision Medicine Market Size (2018-2023)

4.2.4 Europe Precision Medicine Market Size (2018-2023)

4.2.5 Asia-Pacific Precision Medicine Market Size (2018-2023)

4.2.6 Latin America Precision Medicine Market Size (2018-2023)

4.2.7 Middle East & Africa Precision Medicine Market Size (2018-2023)

5 North America

5.1 North America Precision Medicine Revenue by Countries

5.1.1 North America Precision Medicine Revenue by Countries (2018-2023)

5.2 North America PEST Analysis

5.3 United States

5.4 Canada

6 Asia Pacific

6.1 Asia Pacific Precision Medicine Revenue by Countries

6.1.1 Asia Pacific Precision Medicine Revenue by Countries (2018-2023)

6.2 Asia-Pacific PEST Analysis

6.3 China

6.4 Japan

6.5 Korea

6.6 Southeast Asia

6.7 India

6.8 Australia

7 Europe

7.1 Europe Precision Medicine Revenue by Countries

7.1.1 Europe Precision Medicine Revenue by Countries (2018-2023)

7.2 Europe PEST Analysis

7.3 Germany

7.4 France

7.5 UK

7.6 Italy

7.7 Russia

7.8 Spain

7.9 Nordic

8 Latin America

8.1 Latin America Precision Medicine Revenue by Countries

8.1.1 Latin America Precision Medicine Revenue by Countries (2018-2023)

8.2 Latin America PEST Analysis

8.3 Brazil

8.4 Argentina

8.5 Mexico

9 Middle East & Africa

9.1 Middle East & Africa Precision Medicine Revenue by Countries

9.1.1 Middle East & Africa Precision Medicine Revenue by Countries (2018-2023)

9.2 Middle East & Africa PEST Analysis

9.3 Egypt

9.4 South Africa

9.5 UAE

9.6 Turkey

9.7 Saudi Arabia

10 Global Precision Medicine Market Competition, by Players

10.1 Global Precision Medicine Revenue and Market Share by Players

10.2 Market Concentration Rate

10.2.1 Top 3 Precision Medicine Players Market Share in 2022

10.2.2 Top 6 Precision Medicine Players Market Share in 2022

10.2.3 Market Competition Trend

10.3 Precision Medicine Players Head Office, Business Provided

10.4 Precision Medicine Mergers & Acquisitions

10.5 Precision Medicine New Entrants and Expansion Plans

11 Players Profiles

11.1 Moderna, Inc. (U.S.)

11.1.1 Moderna, Inc. (U.S.) Company Profile

11.1.2 Precision Medicine Product Overview

11.1.3 Moderna, Inc. (U.S.) Precision Medicine Market Performance (2018-2023)

11.1.4 Moderna, Inc. (U.S.) Business Overview

11.1.5 Recent Developments and Plans

11.2 Personalis, Inc. (U.S.)

11.2.1 Personalis, Inc. (U.S.) Company Profile

11.2.2 Precision Medicine Product Overview

11.2.3 Personalis, Inc. (U.S.) Precision Medicine Market Performance (2018-2023)

11.2.4 Personalis, Inc. (U.S.) Business Overview

11.2.5 Recent Developments and Plans

11.3 CureVac SE (Germany)

11.3.1 CureVac SE (Germany) Company Profile

11.3.2 Precision Medicine Product Overview

11.3.3 CureVac SE (Germany) Precision Medicine Market Performance (2018-2023)

11.3.4 CureVac SE (Germany) Business Overview

11.3.5 Recent Developments and Plans

11.4 Celldex Therapeutics (U.S.)

11.4.1 Celldex Therapeutics (U.S.) Company Profile

11.4.2 Precision Medicine Product Overview

11.4.3 Celldex Therapeutics (U.S.) Precision Medicine Market Performance (2018-2023)

11.4.4 Celldex Therapeutics (U.S.) Business Overview

11.4.5 Recent Developments and Plans

11.5 BioNTech SE (Germany)

11.5.1 BioNTech SE (Germany) Company Profile

11.5.2 Precision Medicine Product Overview

11.5.3 BioNTech SE (Germany) Precision Medicine Market Performance (2018-2023)

11.5.4 BioNTech SE (Germany) Business Overview

11.5.5 Recent Developments and Plans

11.6 Advaxis, Inc. (U.S.)

11.6.1 Advaxis, Inc. (U.S.) Company Profile

11.6.2 Precision Medicine Product Overview

11.6.3 Advaxis, Inc. (U.S.) Precision Medicine Market Performance (2018-2023)

11.6.4 Advaxis, Inc. (U.S.) Business Overview

11.6.5 Recent Developments and Plans

11.7 Agenus Inc. (U.S.)

11.7.1 Agenus Inc. (U.S.) Company Profile

11.7.2 Precision Medicine Product Overview

11.7.3 Agenus Inc. (U.S.) Precision Medicine Market Performance (2018-2023)

11.7.4 Agenus Inc. (U.S.) Business Overview

11.7.5 Recent Developments and Plans

11.8 Immatics Biotechnologies GmbH (Germany)

11.8.1 Immatics Biotechnologies GmbH (Germany) Company Profile

11.8.2 Precision Medicine Product Overview

11.8.3 Immatics Biotechnologies GmbH (Germany) Precision Medicine Market Performance (2018-2023)

11.8.4 Immatics Biotechnologies GmbH (Germany) Business Overview

11.8.5 Recent Developments and Plans

11.9 Gritstone Oncology (U.S.)

11.9.1 Gritstone Oncology (U.S.) Company Profile

11.9.2 Precision Medicine Product Overview

11.9.3 Gritstone Oncology (U.S.) Precision Medicine Market Performance (2018-2023)

11.9.4 Gritstone Oncology (U.S.) Business Overview

11.9.5 Recent Developments and Plans

11.10 ImmunityBio, Inc. (U.S.)

11.10.1 ImmunityBio, Inc. (U.S.) Company Profile

11.10.2 Precision Medicine Product Overview

11.10.3 ImmunityBio, Inc. (U.S.) Precision Medicine Market Performance (2018-2023)

11.10.4 ImmunityBio, Inc. (U.S.) Business Overview

11.10.5 Recent Developments and Plans

11.11 bioMérieux SA (France)

11.11.1 bioMérieux SA (France) Company Profile

11.11.2 Precision Medicine Product Overview

11.11.3 bioMérieux SA (France) Precision Medicine Market Performance (2018-2023)

11.11.4 bioMérieux SA (France) Business Overview

11.11.5 Recent Developments and Plans

11.12 Bayer AG (Germany)

11.12.1 Bayer AG (Germany) Company Profile

11.12.2 Precision Medicine Product Overview

11.12.3 Bayer AG (Germany) Precision Medicine Market Performance (2018-2023)

11.12.4 Bayer AG (Germany) Business Overview

11.12.5 Recent Developments and Plans

11.13 Pfizer Inc. (U.S.)

11.13.1 Pfizer Inc. (U.S.) Company Profile

11.13.2 Precision Medicine Product Overview

11.13.3 Pfizer Inc. (U.S.) Precision Medicine Market Performance (2018-2023)

11.13.4 Pfizer Inc. (U.S.) Business Overview

11.13.5 Recent Developments and Plans

11.14 GSK plc (U.K.)

11.14.1 GSK plc (U.K.) Company Profile

11.14.2 Precision Medicine Product Overview

11.14.3 GSK plc (U.K.) Precision Medicine Market Performance (2018-2023)

11.14.4 GSK plc (U.K.) Business Overview

11.14.5 Recent Developments and Plans

11.15 F. Hoffmann-La Roche Ltd. (Switzerland)

11.15.1 F. Hoffmann-La Roche Ltd. (Switzerland) Company Profile

11.15.2 Precision Medicine Product Overview

11.15.3 F. Hoffmann-La Roche Ltd. (Switzerland) Precision Medicine Market Performance (2018-2023)

11.15.4 F. Hoffmann-La Roche Ltd. (Switzerland) Business Overview

11.15.5 Recent Developments and Plans

12 Global Precision Medicine Forecast Market Insights by Type

12.1 Global Precision Medicine Revenue Market Forecast by Type (2023-2029)

13 Global Precision Medicine Forecast Market Insights by Application

13.1 Precision Medicine Revenue Market Forecast by Application (2023-2029)

14 Global Market Growth Forecast Insights

14.1 Global Precision Medicine Forecast Market Size (2023-2029)

14.2 Precision Medicine Growth Forecast Insights by Regions

14.2.1 Precision Medicine Revenue Forecast Market Size by Regions (2023-2029)

14.2.2 North America Precision Medicine Forecast Market Size (2023-2029)

14.2.3 Europe Precision Medicine Forecast Market Size (2023-2029)

14.2.4 Asia-Pacific Precision Medicine Forecast Market Size (2023-2029)

14.2.5 Latin America Precision Medicine Forecast Market Size (2023-2029)

14.2.6 Middle East & Africa Precision Medicine Forecast Market Size (2023-2029)

15 Methodology and Data Source

15.1 A Methodology

15.1.1 Research Process

15.1.2 Market Size Estimation

15.1.3 Market Breakdown and Data Triangulation

15.2 B Data Source

15.2.1 Legal Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Global Precision Medicine Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
What trends are influencing the growth of the Global Precision Medicine Market?
New players are entering the Global Precision Medicine Market, while established companies are changing their business models and strategies. This pattern is likely to continue for the foreseeable future.
What is the expected rate of growth in the Global Precision Medicine Market?
From 2025 to 2030, the Global Precision Medicine Market is expected to grow at a compound annual growth rate of YY%, reaching a value of USD XXX Million.
What are the advantages of the Global Precision Medicine Market research study?
The Global Precision Medicine Market research study aids businesses in strategic planning so that they may realize and gain business value from their growth strategies.
What does the future hold for the Global Precision Medicine Industry?
This latest research publication on the Global Precision Medicine Market is an in-depth market tracker that provides a comprehensive assessment of the challenges that manufacturers face in achieving new growth cycles in the current scenario.